Cargando…

Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response

Detalles Bibliográficos
Autores principales:	Kitzmüller, Claudia, Jahn‐Schmid, Beatrice, Kinaciyan, Tamar, Bohle, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767596/ https://www.ncbi.nlm.nih.gov/pubmed/30887520 http://dx.doi.org/10.1111/all.13779

Ejemplares similares

Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen‐allergic patients with apple allergy
por: Kinaciyan, T., et al.
Publicado: (2015)

Adjuvants and Vaccines Used in Allergen-Specific Immunotherapy Induce Neutrophil Extracellular Traps
por: Karacs, Jasmine, et al.
Publicado: (2021)

NSG mice humanized with allergen‐specific T‐cell lines as in vivo model of respiratory allergy
por: Vizzardelli, Caterina, et al.
Publicado: (2020)

T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
por: Reithofer, Manuel, et al.
Publicado: (2023)

T‐cell‐derived cytokines enhance the antigen‐presenting capacity of human neutrophils
por: Samadi, Nazanin, et al.
Publicado: (2019)

Adjuvanting Allergen Extracts for Sublingual Immunotherapy: Calcitriol Downregulates CXCL8 Production in Primary Sublingual Epithelial Cells
por: Pelst, Michael P., et al.
Publicado: (2020)

Recurrent rhombencephalomyelitis associated with allergen immunotherapy by mite antigen sublingual tablets
por: Kawajiri, Masakazu, et al.
Publicado: (2019)

Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
por: Abu El‐Enin, Mohammed A., et al.
Publicado: (2022)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Long-term effects of allergen sublingual immunotherapy
por: Bozek, Andrzej, et al.
Publicado: (2019)

Glutathione-S-Transferase: A Minor Allergen in Birch Pollen due to Limited Release from Hydrated Pollen
por: Deifl, Stephan, et al.
Publicado: (2014)

Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015)

Commentary: Sublingual Allergen Immunotherapy in HIV-Positive Patients
por: Chirumbolo, Salvatore
Publicado: (2016)

Nondaily dosing schedule of allergen-specific sublingual immunotherapy: efficacy and safety
por: Abdelwahab, Heba Wagih, et al.
Publicado: (2023)

Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergen
por: Aliu, Have, et al.
Publicado: (2017)

Sublingual allergen immunotherapy for respiratory allergy: a systematic review
por: Blanco, Carlos, et al.
Publicado: (2018)

Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy
por: Moral, Angel, et al.
Publicado: (2016)

Human neutrophils require short exposure to cytokines and allergen to become functional antigen‐presenting cells
por: Polak, Dominika, et al.
Publicado: (2022)

Acupuncture as an add-on therapy to sublingual allergen-specific immunotherapy for patients with allergic rhinitis
por: Li, Jiang-hua, et al.
Publicado: (2019)

Purification and Characterization of Recombinant Expressed Apple Allergen Mal d 1
por: Kaeswurm, Julia A. H., et al.
Publicado: (2020)

Assessment of stability and compatibility of dermatophagoides and blomia allergen mixture for sublingual immunotherapy
por: Morejón, Maytee Mateo, et al.
Publicado: (2015)

Lung-derived innate cytokines: new epigenetic targets of allergen-specific sublingual immunotherapy
por: Pishdadian, Abbas, et al.
Publicado: (2016)

Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation
por: Janson, Christer, et al.
Publicado: (2018)

Predictors for Short-Term Efficacy of Allergen-Specific Sublingual Immunotherapy in Children with Allergic Rhinitis
por: Liu, Wenlong, et al.
Publicado: (2020)

Sublingual Immunotherapy: How Sublingual Allergen Administration Heals Allergic Diseases; Current Perspective about the Mode of Action
por: Gotoh, Minoru, et al.
Publicado: (2021)

Dramatically decreased T cell responses but persistent IgE upon reduced pollen exposure
por: Van Hemelen, Dries, et al.
Publicado: (2019)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Creation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergens
por: Rosskopf, Sandra, et al.
Publicado: (2016)

In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2015)

Safety, Efficacy, and Preventive Role of Subcutaneous and Sublingual Allergen Immunotherapy for the Treatment of Pediatric Asthma
por: Giannetti, Arianna, et al.
Publicado: (2020)

Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy
por: Marcucci, Francesco, et al.
Publicado: (2012)

FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy
por: Stelmaszczyk-Emmel, Anna, et al.
Publicado: (2015)

486 Therapeutic Effect and Security in Asthmatics Adult Patients Treated with Dermatophagoides Pteronyssinus Allergen Sublingual Immunotherapy
por: Rodríguez, José, et al.
Publicado: (2012)

Recombinant allergens for immunotherapy: state of the art
por: Zhernov, Yury, et al.
Publicado: (2019)

Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background
por: Knapp, Bernhard, et al.
Publicado: (2012)

Comment on “Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review”
por: Kroker, George F., et al.
Publicado: (2012)

Sublingual Immunotherapy for Japanese Cedar Pollinosis Attenuates Asthma Exacerbation
por: Kikkawa, Sayaka, et al.
Publicado: (2019)

Acute systemic reactions to sublingual immunotherapy for house dust mite
por: Janssens, Nicky S., et al.
Publicado: (2020)

Allergen-Specific Immunotherapy in Asthma
por: Jutel, Marek
Publicado: (2014)

New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ(®) tablets
por: Vitiello, Gianfranco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q0puecdrgq98gikiqnu45v3a5s